6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
2h ago	Data at Heart Rhythm 2026 highlight key Boston Scientific therapies
3h ago	Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026
4h ago	Smart Money Quietly Accumulating as Lithium Demand Surges - Early Positioning in Elektros Signals Rare Ground-Floor Opportunity
8h ago	Neusoft Showcases Full-Stack & Global Innovations at Auto China 2026
8h ago	Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026

About

Ionis Pharmaceuticals Inc (NASDAQ:IONS) — investor relations, events, news, and company updates on 6ix.

Latest News

Ionis presents new data from pivotal study of zilganersen in Alexander disease (AxD) at AAN 2026 Annual Meeting

Ionis to hold first quarter 2026 financial results webcast

Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review

Ionis announces changes to Board of Directors

Ionis to present new data supporting DAWNZERA™ (donidalorsen) in hereditary angioedema at 2026 AAAAI Annual Meeting

Financials

Revenue

$943.71 M

Market Cap

$12.35 B

EPS

-2.38

Community Chat

Ask AI